Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
Hiddo J.L. Heerspink(University Medical Center Groningen), Barry M. Brenner(Brigham and Women's Hospital), Tom Greene(University Medical Center Groningen), Gershon Frisch(Jewish General Hospital), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), Gerald J. Beck(Cleveland Clinic), Fan Fan Hou(Southern Medical University), Leung Cb, Andrew S. Levey(Tufts Medical Center), Christoph Wanner(Universitätsklinikum Würzburg), Gabriella Moroni(Humanitas University), Dick de Zeeuw(University Medical Center Groningen), Brendan Barret, Josef Coresh(New York University), Anne‐Lise Kamper, Edmund J. Lewis, Giuseppe Montogrino, Manuel Praga(Universidad Complutense de Madrid), Lesley A. Inker(Tufts Medical Center), Julia B. Lewis, Hocine Tighiouart(Tufts University), Cheuk‐Chun Szeto(Chinese University of Hong Kong), Di Xie(Xuzhou Medical College), Tak Mao Chan(Chinese University of Hong Kong), Eduardo Verde(Hospital General Universitario Gregorio Marañón), Francesco Locatelli(University of Modena and Reggio Emilia), Giuseppe Maschio(Ospedale Civile di Venezia), Fernando C. Fervenza(Mayo Clinic), Enyu Imai(Takara (Japan)), Claudio Pozzi, Ángel Sevillano(Hospital Universitario 12 De Octubre), Christina Fitzner, Bart Maes(AZ Delta), Claudio Ponticelli Montagnino, Francesco Paolo Schena(University of Bari Aldo Moro), Andrew Simon(Harvard University), GG van Essen, Fumiaki Kobayashi(Daiichi-Sankyo (Japan)), Arjan D. van Zuilen, Gavin J. Becker, Hans‐Henrik Parving(University of Copenhagen), Eduardo Gutiérrez(Hospital Universitario 12 De Octubre), Benno U. Ihle, Ron T. Gansevoort(University Medical Center Groningen), Gerald B. Appel(Columbia University Irving Medical Center)
Cited by 372
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k